<DOC>
	<DOCNO>NCT01456013</DOCNO>
	<brief_summary>Contrast-Induced Nephropathy ( CIN ) occur patient pre-existing kidney problem undergo procedure use iodinate contrast medium , cardiac catheterization . RenalGuard Therapy develop enable patient clear contrast kidney significant damage . This study aim enroll patient increase risk develop CIN schedule cardiovascular catheterization . Patients randomize either RenalGuard therapy standard therapy .</brief_summary>
	<brief_title>Evaluation RenalGuardÂ® System Reduce Incidence Contrast Induced Nephropathy At-Risk Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Male nonpregnant female equal great age 18 year old able provide inform consent . Subject schedule undergo elective catheterization procedure Hemodynamically stable At increase risk develop CIN Subject agree followup testing . Class 4 Congestive Heart Failure ( CHF ) document left ventricular ejection fraction &lt; 30 % Is anuric undergone renal replacement therapy within past month , know inability Foley catheter place . Subject hospitalize treat medically change renal function past week ( i.e . dialysis , etc . ) , significant change renal function note time screen . Has document severe Aortic Stenosis . ( Note : Subjects undergone successful replacement repair aortic valve exclude . ) Currently know clinically significant electrolyte imbalance clinically significant arrhythmias compromise subject 's hemodynamic state . Patient severe anemia ( hemoglobin &lt; 8.0 g/dL ) screening Has receive contrast within 10 day procedure plan additional cardiac renal major surgical procedure within 7 day followup period . Has rule Serious Heart Attack within 48 hour plan procedure Has document respiratory insufficiency evidence oxygen saturation &lt; 90 % room air assess day procedure . Planned addition , discontinuation dose adjustment nephrotoxic drug Subject know hypersensitivity furosemide and/or contrast agent use . Subject currently , plan , enrol another clinical study involve use investigational drug device within prior 30 day . Subject pregnant breastfeeding . Subject unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>